Einstein/Montefiore Department of Medicine

In The Media

CBS News interviews Chinazo Cunningham, M.D., M.S., about the growing problem of opioid painkiller abuse and addiction. Dr. Cunningham explains why opioid abuse has increased significantly in recent years, her research on bias on the part of doctors in prescribing and monitoring opioids, and how Einstein has a structured curriculum to teach future doctors how to treat addition. Dr. Cunningham is professor of medicine and family and social medicine at Einstein and associate chief of the division of general internal medicine at Montefiore Medical Center.

(Monday, October 13, 2014)

Dr. Cunningham's Profile
 
 

The New York Times features new research by Elina Jerschow, M.D., that found medications are the cause of most fatal allergic reactions. Dr. Jerschow notes that antibiotics and radiocontrast agents used in imaging studies are the two top medicines responsible for allergic deaths. Dr. Jerschow is assistant professor of medicine at Einstein and director of the Drug Allergy Center at Montefiore Medical Center.

(Monday, October 06, 2014)

Dr. Jerschow's Profile
 
 

Wall Street Journal interviews Judy Wylie-Rosett, Ph.D., about research that suggests artificial sweeteners may raise blood sugar levels by altering the body’s gut bacteria. Dr. Wylie-Rosett notes that the study is important since it is the first to examine how gut microbes contribute to processing real and fake sugars. Dr. Wylie-Rosett is head of the division of health promotion and nutrition research, and professor of epidemiology & population health and of medicine at Einstein.

(Thursday, September 18, 2014)

Dr. Rosett's Profile
 
 

New York Times interviews Kami Kim, M.D., about research that finds the parasite Toxoplasma gondii can manipulate the behavior of its host by switching on genes in brain cells. Research by Dr. Kim has found that a number of pathogens, including leprosy, appear to use DNA methylation to turn genes on and off in the animal it infects. Dr. Kim is professor medicine, of microbiology & immunology and of pathology.

(Friday, August 29, 2014)

Dr. Kim's Profile
 
 

USA Today interviews Belinda Ostrowsky, M.D., about rapid detection tests for Ebola that are in development. The fastest reliable tests for Ebola currently take about three days, which can delay treatment. Dr. Ostrowsky notes that any rapid detection method would benefit patients and healthcare providers. Dr. Ostrowsky is associate professor of clinical medicine at Einstein and director of the Einstein-Montefiore Antibiotic Stewardship Program.

(Friday, August 15, 2014)

Dr. Ostrowsky's Profile
 
 

NPR’s Morning Edition interviews Arturo Casadevall, M.D., Ph.D., on the controversy surrounding research on dangerous lab-made pathogens. Following the mishandling of smallpox by the CDC, the potential exposure of CDC scientists to live anthrax and even the recent the spread of Ebola, biologists and others are calling on the National Academy of Sciences to provide guidance on when and under what conditions research using lab-manipulated pathogens should be allowed to move forward. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein. (Dr. Casadevall’s interview begins at 4:38 in the audio version)

(Wednesday, August 13, 2014)

Dr. Casadevall's Profile
 
 

NBC News interviews Arturo Casadevall, M.D., Ph.D., about the history of using serums and antibodies to combat disease in light of an experimental Ebola treatment. Dr. Casadevall notes that antibody treatments, which are most known for fighting infectious diseases, have also had an enormous impact on treating certain cancers, such as breast and colon cancer. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.

(Wednesday, August 06, 2014)

Dr. Casadevall's Profile
 
 

The Washington Post reports on research by Joe Verghese, M.B.B.S., that predicts pre-dementia by measuring walking speed and cognitive abilities. The quick, low-tech test determined that 1 in 10 older adults have pre-dementia. The study involved 27,000 people in 7 countries. It found that those who had unusually slow walking speed and cognitive complaints are twice as likely to develop dementia within 12 years. Dr. Verghese is professor of neurology at Einstein and chief of the division of geriatrics at Einstein and Montefiore Medical Center.

(Tuesday, August 05, 2014)

Dr. Verghese's Profile
 
 

The Washington Post reports on research by Joe Verghese, M.B.B.S., that predicts pre-dementia by measuring walking speed and cognitive abilities. The quick, low-tech test determined that 1 in 10 older adults have pre-dementia. The study involved 27,000 people in 7 countries. It found that those who had unusually slow walking speed and cognitive complaints are twice as likely to develop dementia within 12 years. Dr. Verghese is professor of neurology at Einstein and chief of the division of geriatrics at Einstein and Montefiore Medical Center.

(Tuesday, August 05, 2014)

Dr. Verghese's Profile
 
 

The New York Times Magazine quotes Paul Frenette, M.D., in an article on research linking the nervous system to inflammation. Dr. Frenette has discovered that nerves play a key role in triggering prostate cancer, which is also associated with inflammation. Dr. Frenette is professor of medicine and of cell biology and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.

(Tuesday, May 27, 2014)

Dr. Frenette's Profile
 
 

The New York Times Magazine quotes Paul Frenette, M.D., in an article on research linking the nervous system to inflammation. Dr. Frenette has discovered that nerves play a key role in triggering prostate cancer, which is also associated with inflammation. Dr. Frenette is professor of medicine and of cell biology and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.

(Tuesday, May 27, 2014)

Dr. Frenette's Profile
 
 

NPR interviews Arturo Casadevall, M.D., Ph.D., about balancing scientific openness with potential security risks in light of research that omitted key details about the deadly Botulism toxin. Dr. Casadevall noted there needs to be a standard for handling such difficult situations and is calling for the creation of a national board to recommend what information should be kept secret. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.

(Thursday, April 24, 2014)

Dr. Casadevall's Profile
 
 

The Washington Post interviews Brian Currie, M.D., M.P.H., about a new medical research data-sharing network to house the records of nearly 30 million Americans. The Patient-Centered Outcomes Research Institute’s network will make it easier to identify patients who could be invited to join clinical trials and conduct comparative effectiveness and clinical outcomes research. Dr. Currie is professor of clinical medicine and of clinical epidemiology & population health at Einstein and assistant dean for clinical research at Montefiore Medical Center.

(Friday, April 18, 2014)

Dr. Currie's Profile
 
 

The Washington Post interviews Brian Currie, M.D., M.P.H., about a new medical research data-sharing network to house the records of nearly 30 million Americans. The Patient-Centered Outcomes Research Institute’s network will make it easier to identify patients who could be invited to join clinical trials and conduct comparative effectiveness and clinical outcomes research. Dr. Currie is professor of clinical medicine and of clinical epidemiology & population health at Einstein and assistant dean for clinical research at Montefiore Medical Center.

(Friday, April 18, 2014)

Dr. Currie's Profile
 
 

Wall Street Journal ran an op-ed co-written by Arturo Casadevall, M.D., Ph.D., that supports turning the National Institutes of Health (NIH) grant process into a lottery. Dr. Casadevall and co-author Ferric Fang, M.D., of the University of Washington, cite research that highlights problems with the current peer review grant process, including bias influencing funding decisions. They suggest that a lottery would make the process more transparent and alleviate stress on scarce resources. Views expressed in the op-ed, available only via subscription, represent those of Drs. Casadevall and Fang and not Albert Einstein College of Medicine. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.

(Thursday, April 17, 2014)

Dr. Casadevall's Profile
 
 
First Page | Previous Page | Page of 14 | Next Page | Last Page
Click here to log in